Merck is ready to acquire large biotech companies with established sales to boost its business and swell the pipeline of experimental medicines, its chief executive said on Wednesday.
"As part of our strategy going forward we are aggressively looking at alliances and join ventures and acquisitions of biotech companies," Richard Clark told Reuters on the sidelines of the World Economic Forum in Davos.
"I'm not only looking for late-stage compounds, or the ability to help our scientific advantage. We're also looking to have a company that has in-line revenue and that has stable products to begin with," he added.
Now why else might Clark be in Switzerland?
Source: Ben Hirschler
UPDATE: 21/09/06 Merck KGaA are buying Serono...........
Go here for the latest PharmaGossip
No comments:
Post a Comment